Metabolic Acidosis
50
7
10
25
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.0%
3 terminated out of 50 trials
89.3%
+2.8% vs benchmark
28%
14 trials in Phase 3/4
32%
8 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (50)
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
Sodium Bicarbonate for Critically Ill Patients With Metabolic Acidosis and Acute Kidney Injury
A Study of Tris-Hydroxymethyl Aminomethane (THAM) Versus Sodium Bicarbonate in Cardiac Surgical Patients
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD)
A Study on Bedside Formate Assay as a Diagnostic Tool in Methanol Poisoning
SODium BICarbonate for Metabolic Acidosis in the ICU
Adding Urea to the Final Dialysis Fluid
Explorative Study to Investigate the Acid-base Response to Sodium and Potassium Salts in Patients With Chronic Kidney Disease.
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients
PLADO for Conservative Management of CKD
Correlation Between Base Excess in Patients Upon Admission to the ICU and Platelet Count Trend in the Following Days
Bicarbonate Administration and Cognitive Function in Midlife and Older Adults With CKD
Prevention of Metabolic Acidosis in Preterm Neonates by Replacing Sodium Chloride With Sodium Acetate in Parenteral Nutrition
Sodium Bicarbonate for the Treatment of Severe Metabolic Acidosis With Moderate or Severe Acute Kidney Injury in ICU
Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill
Intraoperative Cell Salvage and Postoperative Acidosis
Diabetic Ketoacidosis Diagnosis and Management
Reduction of Metabolic Acidosis in Patients With Chronic Kidney Disease in Stage 4 and 5
The Relationship of Developing Metabolic Acidosis With Antiepleptic Drugs in Craniotomy Operations